Efficacy and safety of intravenous laronidase for mucopolysaccharidosis type I: A systematic review and meta-analysis

Mucopolysaccharidosis type I (MPS I) is an autosomal recessive disease caused by deficient activity of alpha-L-iduronidase. Intravenous (IV) enzyme replacement therapy (ERT) with laronidase is currently used for treating patients with MPS I. OBJECTIVE: To evaluate the efficacy and safety of IV laron...

全面介紹

Na minha lista:
書目詳細資料
發表在:PLoS One
Main Authors: Dornelles, Alícia Dorneles, Artigalás, Osvaldo, da Silva, André Anjos, Ardila, Dora Lucia Vallejo, Alegra, Taciane, Pereira, Tiago Veiga, Vairo, Filippo Pinto e, Schwartz, Ida Vanessa Doederlein
格式: Artigo
語言:Inglês
出版: Public Library of Science 2017
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5578671/
https://ncbi.nlm.nih.gov/pubmed/28859139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0184065
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍